ivosidenib,azacitidine
servier
['azacitidine,(-oral azaci),(-azacitidine oral)', 'ivosidenib', 'leukemia', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops)']
congress #asco22 | st phane de botton describes the molecular characterization of clinical response in patients with newly diagnosed aml with ivosidenib + azacitidine versus placebo + aza. cr + crh: 60% ivo + aza vs 36.3% with the placebo + aza #leusm #leukemia 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm